肝移植受者心脏与肺血管疾病风险评估的多学科方法:证据评估与共识推荐
该综述由多学科专家小组撰写,获美国移植学会肝肠与胸科重症实践社区认可,针对肝移植候选者年龄更大、病情更重、心血管合并症更多的现状,评估了心脏与肺血管疾病的诊断及干预措施。文中指出肝硬化心肌病在肝硬化患者中高达30%,表现为心输出量增加和心室对应激反应降低;现有无创检查对亚临床冠脉和心肌疾病敏感性低,肝移植术中血流动力学改变可显露隐匿心血管病。综述提供了诊断与管理的关键要点和实践推荐,为临床医生提供指导并指明知识空白。
要点
- 肝硬化心肌病在肝硬化患者中高达30%,特征为心输出量增加和心室对应激反应降低,使围术期管理具有挑战性。
- 现有无创检查评估亚临床冠脉和心肌疾病敏感性低。
- 肝移植术中血流动力学改变可在术中或术后即刻显露隐匿性心血管疾病。
- 该综述由多学科专家小组撰写,获美国移植学会肝肠与胸科重症实践社区认可,提供诊断与管理实践推荐。
适用人群与场景
- 肝移植候选者,当前人群较以往年龄更大、病情更重、心血管合并症更多。
- 肝硬化患者,其中高达30%存在肝硬化心肌病。
诊断标准与关键阈值
- 肝硬化心肌病:特征为心输出量增加和心室对应激反应降低,在肝硬化患者中高达30%。
红旗征与不能漏的情况
- 肝移植术中血流动力学改变可在术中或术后即刻显露隐匿性心血管疾病。
研究设计与关键结果
- 综述由多学科专家小组撰写,获美国移植学会肝肠与胸科重症实践社区认可,对肝移植候选者心脏与肺血管疾病的诊断及干预措施进行批判性评估,并提供关键要点和实践推荐。
证据类型、等级与局限
- 证据类型:多学科专家综述与共识推荐,获美国移植学会肝肠与胸科重症实践社区认可。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,现有无创检查评估亚临床冠脉和心肌疾病敏感性低,肝移植术中血流动力学改变可显露隐匿心血管病,需关注围术期心血管风险评估。
指南或共识出处
- 美国移植学会肝肠与胸科重症实践社区认可的综述(American Society of Transplantation Liver and Intestine and Thoracic and Critical Care Communities of Practice)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Liver transplant (LT) candidates today are older, have greater medical severity of illness, and have more cardiovascular comorbidities than ever before. In addition, there are specific cardiovascular responses in cirrhosis that can be detrimental to the LT candidate. Cirrhotic cardiomyopathy, a condition characterized by increased cardiac output and a reduced ventricular response to stress, is present in up to 30% of patients with cirrhosis, thus challenging perioperative management. Current noninvasive tests that assess for subclinical coronary and myocardial disease have low sensitivity, and altered hemodynamics during the LT surgery can unmask latent cardiovascular disease either intraoperatively or in the immediate postoperative period. Therefore, this review, assembled by a group of multidisciplinary experts in the field and endorsed by the American Society of Transplantation Liver and Intestine and Thoracic and Critical Care Communities of Practice, provides a critical assessment of the diagnosis of cardiac and pulmonary vascular disease and interventions aimed at managing these conditions in LT candidates. Key points and practice-based recommendations for the diagnosis and management of cardiac and pulmonary vascular disease in this population are provided to offer guidance for clinicians and identify gaps in knowledge for future investigations.
参考来源
- VanWagner LB, Harinstein ME, Runo JR, et al. Multidisciplinary approach to cardiac and pulmonary vascular disease risk assessment in liver transplantation: An evaluation of the evidence and consensus recommendations. Am J Transplant. 2017. PMID: 28985025. doi:10.1111/ajt.14531
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。